href="#ulink_bc9ea829-9f00-5d1d-8d9f-5d6ac4b69bc1">Devices Conclusions References CHAPTER 78: Acute and Chronic Mesenteric Ischemia Introduction Acute mesenteric ischemia Chronic mesenteric ischemia Technical considerations Post‐procedure follow‐up Complications Conclusions References CHAPTER 79: Renal Artery Interventions Renal artery stenosis Natural history and clinical outcomes Indications for screening Diagnosis Treatment options for ARAS Technical aspects of renal endovascular intervention for renal artery stenosis References CHAPTER 80: Endovascular Interventions for the Pelvis Introduction Uterine artery embolization Prostatic artery embolization Penile revascularization Conclusions References SECTION III: Peripheral Arterial and Venous Disease CHAPTER 81: Iliac Interventions Clinical presentation and diagnosis Percutaneous intervention Aorto‐iliac stenoses Chronic totally occlusive lesions Stent selection: self‐expandable and balloon expandable; covered and uncovered Bifurcation lesions Predictive factors Complications Conclusions References CHAPTER 82: Superficial Femoral Artery Interventions Treatment of patients with PAD Endovascular treatment Contemporary endovascular treatment Balloon angioplasty, bare metal stent Drug‐eluting stents/balloons Conclusions References CHAPTER 83: Popliteal Artery Interventions Interventions for popliteal artery disease Balloon angioplasty Stenting Adjunctive endovascular technologies Atherectomy Popliteal artery aneurysms Conclusions References CHAPTER 84: Below the Knee Interventions in Critical Limb Ischemia Background Evaluation of the lower extremity arterial system Approach to BTK intervention Endovascular management of below the knee critical limb ischemia Percutaneous transluminal angioplasty Modified angioplasty techniques Complications of endovascular procedures Conclusions References CHAPTER 85: Subclavian, Vertebral, and Upper Extremity Vascular Disease Subclavian and upper extremity arterial disease Vertebral artery disease References CHAPTER 86: Antithrombotic Strategies in Endovascular Interventions Pathophysiology Aspirin Ticlopidine Clopidogrel Other ADP receptor antagonists Dipyridamole Vorapaxar Low molecular weight heparins Glycoprotein IIb/IIIa receptor antagonists Vitamin K antagonist Cilostazol Bivalirudin Direct Oral Anticoagulant Agents (DOACs) Conclusions References CHAPTER 87: Chronic Venous
